Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

F-Star Therapeutics Inc (NQ: FSTX )

6.520 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.520
Bid (Size) 6.430 (10)
Ask (Size) 6.870 (1)
Prev. Close 6.520
Today's Range 6.520 - 6.520
52wk Range 2.070 - 8.360
Shares Outstanding 21,584,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga

Performance

YTD
+21.64%
+21.64%
1 Month
+4.99%
+4.99%
3 Month
+173.95%
+173.95%
6 Month
+70.23%
+70.23%
1 Year
+15.81%
+15.81%

More News

Read More
FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
F-star Therapeutics Shares Are Rallying Today - Read Why
Via Benzinga
Recap: F-star Therapeutics Q1 Earnings
Via Benzinga
Week In Review: InvoX, A Sino Biopharma Company, To Pay $161 Million To Acquire F-Star
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
Via Benzinga
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
From Kahn Swick & Foti, LLC
Via Business Wire
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Jumps Over 100 Points; Applied Therapeutics Shares Plummet
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Market Rebound Resumes, Dow Up Triple Digits
Via Talk Markets
Dow Jones Turns Lower; F-star Therapeutics Shares Spike Higher
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
Via Benzinga
FSTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Via Benzinga
U.S. Markets Open Higher; Jobless Claims Drop To 229,000
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 14, 2022
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.